Head of Global Commercial Financial Planning & Analysis
Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases. Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality, and is now advancing a robust pipeline of investigational RNAi therapeutic medicines, including five programs in late-stage development. Alnylam currently has two commercial RNAi therapeutic products. The first product is approved in the U.S., EU, Canada, Japan, and Switzerland for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults and the second product is approved in the U.S. for the treatment of adults with acute hepatic porphyria (AHP). Alnylam also has a deep pipeline of investigational medicines, including five product candidates that are in late-stage development. Headquartered in Cambridge, Mass., Alnylam employs over 1,300 people in 18 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work five years in a row (2015-2019), a Great Place to Work in the U.K. and Switzerland in 2019 and Science Magazine's #1 Top Employer in 2019. Please visit www.alnylam.com for more information.
We are seeking a global leader as the Head of Global Commercial Financial Planning and Analysis reporting to the Chief Financial Officer, who will be a strategic thought-partner to the President of Alnylam, focusing on global commercial operations and medical affairs. The successful candidate will be a hands-on leader with global pharmaceutical / biotech experience and will lead in the following areas: local country statutory accounting outside the US, financial analysis, budgeting and forecasting, and decision support.
The role will drive continuous process improvements and best practices to enhance the effectiveness and efficiency of the planning and reporting processes in support of the global commercial organization. The role will be responsible for consolidating global commercial revenue and expense results on a monthly basis, understanding actual performance vs. forecast, supporting development of plans to enhance performance, and ensuring key insights are communicated internally.
The role will oversee a team to provide support across the regions where Alnylam has established its commercial operations --- US, CEMEA (Canada, Europe, Middle East, Africa), Asia Pacific, and Latin America.
The ideal candidate for this role will have experience in a fast- paced high growth environment. Excellent communication, leadership, and technical skills will be essential for this role as well as a passion to be a part of the company's growth.
Summary of Key Responsibilities
Lead support for President, Alnylam, including but not limited to statutory accounting, budgets, forecasts, management reporting, and decision support
Develop and continuously streamline process to translate information from enterprise reporting platform to management presentations
Create and oversee process to track commercial and medical headcount and staff-costs versus forecast and budget
Develop country level management reporting to enable review of local country commercial results
Prepare monthly global commercial consolidated reporting package to highlight key business results & insights & present results to Global Commercial Leadership Team
Oversee ex-US local country statutory accounting, ensuring the highest standards of financial control and compliance in-line with Alnylam's controllership function and with the Sarbanes-Oxley Act
Provide support & input on behalf of Global Commercial into the quarterly reporting processes at Alnylam --- 10Q, earnings releases, earnings presentations, etc.
Special projects and ad hoc analyses as required by CFO and management
Mentor and develop Global Commercial FP&A team in order to achieve department and company goals
Must have 15 years' experience in financial planning and analysis roles
Prior pharmaceutical / biotech FP&A experience supporting global commercial operations is strongly preferred
Bachelor's Degree in Finance / Accounting, MBA a plus
Strong leadership, problem solving, management and communication skills
Excellent interpersonal skills and ability to work effectively with multiple functions
Ability to lead and influence cross functional teams
Self-starter who can manage through ambiguity, learn on the fly, handle multiple priorities and perform job responsibilities accurately while working in a high energy, deadline-driven, and fast-paced environment
Experience and ability to develop and maintain complex financial models to generate key insights
Maintain a positive, flexible, client-service attitude with business teams
Strong communication, organizational and leadership skills
Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment.
Alnylam Pharmaceuticals, Inc.